Dole plc Reports Third Quarter 2021 Financial Results
Dole plc (NYSE: DOLE) reported its Q3 2021 results, emphasizing a Pro-Forma Revenue of $2.32 billion, a slight increase from Q3 2020. The Pro-Forma Adjusted EBITDA fell by 35.4% to $59.7 million, attributed to inflationary pressures and supply chain issues. Year-to-date figures show Pro-Forma Revenue rose 4.5% to $7.08 billion, while Pro-Forma Adjusted Net Income increased 22.5% to $131.6 million. The company maintains full-year targets of $9.2 to $9.4 billion in revenue and $390 to $400 million in EBITDA. A quarterly dividend of $0.08 per share is declared.
- Year-to-date Pro-Forma Revenue increased by 4.5% to $7.08 billion.
- Pro-Forma Adjusted Net Income for YTD 2021 increased by 22.5% to $131.6 million.
- Full-year Pro-Forma revenue target set between $9.2 billion and $9.4 billion.
- Pro-Forma Adjusted EBITDA decreased by 35.4% to $59.7 million in Q3 2021.
- Pro-Forma Adjusted Fully Diluted EPS fell to $0.04 from $0.32 year-over-year.
Highlights for the three and nine months of 2021 include:
-
Merger of Total Produce plc (“TP”) and
Dole Food Company (“DFC”) to formDole plc -
IPO of
Dole plc onJuly 30, 2021 , raising net proceeds of$398.9 million -
Completed
debt refinancing$1.4 billion - Strong results delivered within a complex economic environment
- Diversified business model and wide geographic footprint provide resilience
- Net Debt / Pro-Forma LTM Adjusted EBITDA 2.76x
-
Dividend of
per share declared for the quarter$0.08 -
Full year Pro-Forma Revenue target
-$9.2 billion $9.4 billion -
Full year Pro-Forma Adjusted EBITDA target
-$390 million $400 million
Q3’21 |
Q3’20 |
YTD’21 |
YTD’20 |
YTD Variance |
||||||
Pro-Forma Revenue - $’m (1), (2) |
2,317 |
2,310 |
7,075 |
6,768 |
+ |
|||||
Pro-Forma Adjusted EBITDA - $’m (1), (2) |
59.7 |
92.4 |
337.7 |
299.9 |
+ |
|||||
Pro-Forma Adjusted Net Income - $’m (1), (2) |
3.7 |
30.9 |
131.6 |
107.5 |
+ |
|||||
Pro-Forma Adjusted Fully Diluted EPS - $ (1), (2) |
|
|
|
|
+ |
Note 1: This press release contains pro-forma financial information. The unaudited pro-forma consolidated financial statements for
The financial statements filed today with the
Note 2:
Commenting on the results,
“Dole plc has delivered a strong performance for the first nine months of 2021 in the context of inflationary pressures across our North American and European markets during the third quarter. With industry wide supply chain congestion and labor shortages, our diversified business model has proven itself to be responsive and resilient. We are very pleased with the response of our divisions and people in the face of these challenges and are confident in our ability to meet our full year outlook.”
Pro-Forma Revenue for the third quarter increased
Pro-Forma Revenue increased
Pro-Forma Adjusted EBITDA for the third quarter decreased
Pro-Forma Adjusted EBITDA for the first nine months of 2021 increased
Pro-Forma Adjusted Net Income for the third quarter decreased
Pro-Forma Adjusted Net Income for the first nine months of 2021 increased
Selected Pro-Forma Quarterly Segmental Financial Information
Segmental Information | ||||||||||||||||||
2021 |
||||||||||||||||||
Q1 | Q2 | Q3 | YTD Q3 | |||||||||||||||
Revenue | $'000 | $'000 | $'000 | $'000 | ||||||||||||||
Fresh Fruit | 755,270 |
|
784,772 |
|
676,843 |
|
2,216,885 |
|
||||||||||
Fresh Vegetables | 327,692 |
|
332,273 |
|
323,779 |
|
983,744 |
|
||||||||||
419,985 |
|
425,373 |
|
456,164 |
|
1,301,522 |
|
|||||||||||
795,650 |
|
953,932 |
|
879,422 |
|
2,629,004 |
|
|||||||||||
Intersegment | (18,750 |
) |
(18,750 |
) |
(18,750 |
) |
(56,250 |
) |
||||||||||
Total | 2,279,847 |
|
2,477,600 |
|
2,317,458 |
|
7,074,905 |
|
||||||||||
Adjusted EBITDA | ||||||||||||||||||
Fresh Fruit | 92,546 |
|
86,685 |
|
17,891 |
|
197,122 |
|
||||||||||
Fresh Vegetables | 4,679 |
|
(1,408 |
) |
1,057 |
|
4,328 |
|
||||||||||
10,421 |
|
18,444 |
|
4,588 |
|
33,453 |
|
|||||||||||
25,298 |
|
41,354 |
|
36,191 |
|
102,843 |
|
|||||||||||
Total | 132,944 |
|
145,075 |
|
59,727 |
|
337,746 |
|
||||||||||
2020 |
||||||||||||||||||
Q1 | Q2 | Q3 | YTD Q3 | Q4 | FY | |||||||||||||
Revenue | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | ||||||||||||
Fresh Fruit | 763,646 |
|
712,712 |
|
682,194 |
|
2,158,552 |
|
636,987 |
|
2,795,539 |
|
||||||
Fresh Vegetables | 308,692 |
|
313,996 |
|
320,543 |
|
943,231 |
|
324,375 |
|
1,267,606 |
|
||||||
381,999 |
|
416,993 |
|
438,283 |
|
1,237,275 |
|
475,995 |
|
1,713,270 |
|
|||||||
742,871 |
|
852,110 |
|
886,443 |
|
2,481,424 |
|
781,524 |
|
3,262,948 |
|
|||||||
Intersegment | (17,490 |
) |
(17,489 |
) |
(17,490 |
) |
(52,469 |
) |
(17,489 |
) |
(69,958 |
) |
||||||
Total | 2,179,718 |
|
2,278,322 |
|
2,309,973 |
|
6,768,013 |
|
2,201,392 |
|
8,969,405 |
|
||||||
Adjusted EBITDA | ||||||||||||||||||
Fresh Fruit | 61,511 |
|
55,509 |
|
38,199 |
|
155,219 |
|
17,491 |
|
172,710 |
|
||||||
Fresh Vegetables | 8,516 |
|
8,431 |
|
11,496 |
|
28,443 |
|
11,100 |
|
39,543 |
|
||||||
12,953 |
|
16,811 |
|
9,631 |
|
39,395 |
|
14,424 |
|
53,819 |
|
|||||||
14,666 |
|
29,134 |
|
33,084 |
|
76,884 |
|
28,825 |
|
105,709 |
|
|||||||
Total | 97,646 |
|
109,885 |
|
92,410 |
|
299,941 |
|
71,840 |
|
371,781 |
|
Fresh Fruit
Pro-Forma Revenue for the third quarter was down
Pro-forma Revenue for the first nine months of 2021 increased
Pro-Forma Adjusted EBITDA for the third quarter was down
Pro-Forma Adjusted EBITDA for the first nine months of 2021 increased
Fresh Vegetables
Pro-Forma Revenue for the third quarter increased
Pro-Forma Revenue for the first nine months of 2021 increased
Pro-forma Adjusted EBITDA for the third quarter decreased by
Pro-Forma Adjusted EBITDA for the first nine months decreased
Pro-Forma Revenue for the third quarter increased
Pro-Forma Revenue for the first nine months increased
Pro-Forma Adjusted EBITDA for the third quarter decreased
Pro-Forma Adjusted EBITDA for the first nine months was down
Pro-forma Revenue for the third quarter decreased
Pro-Forma Revenue for the first nine months is up
Pro-Forma Adjusted EBITDA for the third quarter was up
Pro-forma Adjusted EBITDA for the first nine months is
Net debt
Net Debt is the primary measure used by management to analyze the Company’s capital structure and financial leverage. Net debt is a non-GAAP financial measure, calculated as cash and cash equivalents, less current and long-term debt. It also excludes debt discounts and debt issuance costs. The calculation of Net Debt and Financial Leverage as at
$'000 | |||
Cash and cash equivalents | (234,214 |
) |
|
Bank overdrafts | 27,579 |
|
|
Notes payable and current portion of long-term debt, net | 52,241 |
|
|
Long-term debt, net | 1,262,334 |
|
|
1,107,940 |
|
||
Less debt discounts and debt issuance costs | 22,368 |
|
|
Net Debt | 1,130,308 |
|
|
Pro-Forma Adjusted EBITDA | |||
Pro-Forma Adjusted EBITDA Q4 2020 | 71,840 |
|
|
Pro-Forma Adjusted EBITDA YTD Q3 2021 | 337,746 |
|
|
Pro Forma Adjusted EBITDA for 12 months ended |
409,586 |
|
|
Net Debt / Pro-Forma Adjusted EBTIDA for 12 months | 2.76 times |
Capital Expenditure
Capital expenditure for the year to date is
Outlook for FY21
For the twelve months ending
Dividend
On
Pro-Forma Financial Statements
Pro-Forma Methodology
The methodology used to prepare the unaudited Pro-Forma consolidated financial statements for
-
All associated Transaction costs reflected on
January 1, 2020 . -
Effective tax rate for 2020 (
28.5% ) and 2021 (25% ). -
Applying the results of the Purchase Price Allocation (“PPA”) exercise to
January 1, 2020 :-
Reversal of fair value uplift to banana and pineapple inventory and bearer plants. DFC accounts for agricultural costs in accordance with ASC 905 Agriculture for all crops except pineapples and bananas due to their continuous cycle of production. At the acquisition balance sheet date previously uncapitalized pineapple and banana costs are required to be recognized at their fair value to reflect the biological transformation of these crops. This is an uplift of
in relation to inventory and$35.0 million in relation to bearer plants. These fair value uplifts will be amortized in the income statement over the remaining growth and harvest cycle for the inventory element and over the life of the plants for the bearer plants. In the YTD Q3 2020 this amortization amounted to$68.0 million .$86.0 million -
2020 and 2021 Pro-Forma results reflect a reduction in the depreciation charge of
. This is a function of the asset values increasing as a result of the PPA exercise offset by an increase in the estimated useful lives of the assets.$4.0 million - The interest expense for both years reflects the outcome of the refinancing.
-
Fair value loss on TP’s investment in DFC recorded on
January 1, 2020 .
-
Reversal of fair value uplift to banana and pineapple inventory and bearer plants. DFC accounts for agricultural costs in accordance with ASC 905 Agriculture for all crops except pineapples and bananas due to their continuous cycle of production. At the acquisition balance sheet date previously uncapitalized pineapple and banana costs are required to be recognized at their fair value to reflect the biological transformation of these crops. This is an uplift of
-
TP’s pickup of its
45% share of DFC’s net income has been eliminated. - EPS is calculated using shares in issue following the IPO and additional share issuances.
-
There is an adjustment in both years to reflect estimated ongoing incremental public company costs of
annualized.$14.0 million
Pro-Forma Statement of Operations – for the three months ended
Q3 2021 | Q3 2020 | |||||||
$'000 | $'000 | |||||||
Revenues, net |
|
2,317,458 |
|
|
2,309,973 |
|
||
Cost of sales |
|
(2,179,456 |
) |
|
(2,163,904 |
) |
||
Gross profit |
|
138,002 |
|
|
146,069 |
|
||
Selling, marketing and general and administrative expenses |
|
(120,297 |
) |
|
(123,597 |
) |
||
Loss on disposal of business |
|
(2,134 |
) |
|
- |
|
||
Gain on asset sales |
|
4,870 |
|
|
4,872 |
|
||
Operating income |
|
20,441 |
|
|
27,344 |
|
||
Other income (loss) |
|
15,441 |
|
|
(2,784 |
) |
||
Interest income |
|
1,138 |
|
|
1,282 |
|
||
Interest expense |
|
(11,431 |
) |
|
(11,431 |
) |
||
Income from continuing operations before income taxes and equity earnings |
|
25,589 |
|
|
14,411 |
|
||
Income tax provision |
|
3,673 |
|
|
4,326 |
|
||
Equity in net earnings of investments accounted for under the equity method |
|
7,901 |
|
|
6,034 |
|
||
Income from continuing operations, net of income taxes |
|
37,163 |
|
|
24,771 |
|
||
Net income |
|
37,163 |
|
|
24,771 |
|
||
Less: Net income attributable to noncontrolling interests |
|
(7,270 |
) |
|
(6,215 |
) |
||
Net income attributable to |
|
29,893 |
|
|
18,556 |
|
||
Earnings per share: | ||||||||
Net income per share - Basic | $ |
0.32 |
|
$ |
0.20 |
|
||
Net income per share - Diluted | $ |
0.31 |
|
$ |
0.20 |
|
||
Weighted average shares outstanding ('000) | ||||||||
Basic |
|
94,878 |
|
|
94,878 |
|
||
Diluted |
|
95,030 |
|
|
95,030 |
|
Pro-Forma Statement of Operations – for the nine months ended
2021 |
2020 |
|||||||
YTD Q3 | YTD Q3 | |||||||
$'000 | $'000 | |||||||
Revenues, net |
|
7,074,905 |
|
|
6,768,013 |
|
||
Cost of sales |
|
(6,489,733 |
) |
|
(6,316,759 |
) |
||
Gross profit |
|
585,172 |
|
|
451,254 |
|
||
Selling, marketing and general and administrative expenses |
|
(378,888 |
) |
|
(358,032 |
) |
||
Merger transaction, litigation settlement and other related costs, net |
|
- |
|
|
(29,000 |
) |
||
Loss on disposal of business |
|
(595 |
) |
|
- |
|
||
Impairment of PP&E |
|
- |
|
|
(1,210 |
) |
||
Gain on asset sales |
|
12,381 |
|
|
7,843 |
|
||
Operating income |
|
218,070 |
|
|
70,855 |
|
||
Other income (loss) |
|
19,811 |
|
|
(11,611 |
) |
||
Interest income |
|
3,209 |
|
|
3,918 |
|
||
Interest expense |
|
(34,385 |
) |
|
(34,385 |
) |
||
Income from continuing operations before income taxes and equity earnings |
|
206,705 |
|
|
28,777 |
|
||
Income tax provision |
|
(43,290 |
) |
|
(8,731 |
) |
||
Equity in net earnings of investments accounted for under the equity method |
|
17,597 |
|
|
9,918 |
|
||
Income from continuing operations, net of income taxes |
|
181,012 |
|
|
29,964 |
|
||
Loss from discontinued operations, net of income taxes |
|
- |
|
|
(43 |
) |
||
Net income |
|
181,012 |
|
|
29,921 |
|
||
Less: Net income attributable to noncontrolling interests |
|
(21,225 |
) |
|
(17,066 |
) |
||
Net income attributable to |
|
159,787 |
|
|
12,855 |
|
||
Earnings per share: | ||||||||
Net income per share - Basic | $ |
1.68 |
|
$ |
0.14 |
|
||
Net income per share - Diluted | $ |
1.68 |
|
$ |
0.14 |
|
||
Weighted average shares outstanding ('000) | ||||||||
Basic |
|
94,878 |
|
|
94,878 |
|
||
Diluted |
|
95,030 |
|
|
95,030 |
|
Reconciliation from Pro-Forma Net Income to Pro-Forma Adjusted EBITDA – for the three months ended
Q3 2021 | Q3 2020 | |||||
$'000 | $'000 | |||||
Net income | 37,163 |
|
24,771 |
|
||
Loss from discontinued operations, net of income taxes | - |
|
- |
|
||
Interest expense from continuing operations | 11,431 |
|
11,431 |
|
||
Income tax expense (benefit) from continuing operations | (3,673 |
) |
(4,326 |
) |
||
EBIT | 44,921 |
|
31,876 |
|
||
Depreciation | 29,368 |
|
26,553 |
|
||
Amortization | 2,664 |
|
2,993 |
|
||
Net unrealized (gain) loss on derivative instruments | 627 |
|
1,071 |
|
||
Fair value movement on contingent consideration | 30 |
|
56 |
|
||
Net unrealized (gain) loss on foreign denominated intercompany borrowings | (3,229 |
) |
6,021 |
|
||
Restructuring charges / onerous leases | (125 |
) |
487 |
|
||
Fair value uplift on biological assets and pineapple plants | - |
|
17,021 |
|
||
(Gain) on asset sales | (4,610 |
) |
(5,325 |
) |
||
(Gain) loss on disposal of a business | 2,134 |
|
- |
|
||
Fair value (gain) loss of other acquisitions | (5,304 |
) |
- |
|
||
COVID-19 | - |
|
7,872 |
|
||
Insurance proceeds / disposals / asset write downs | (9,838 |
) |
- |
|
||
Legal matters | - |
|
(56 |
) |
||
Dole plc Share of Joint Ventures: | ||||||
Interest expense | 384 |
|
370 |
|
||
Income tax | 780 |
|
1,429 |
|
||
Depreciation | 953 |
|
1,367 |
|
||
Amortization | 972 |
|
675 |
|
||
Adjusted EBITDA | 59,727 |
|
92,410 |
|
Reconciliation from Pro-Forma Net Income to Pro-Forma Adjusted EBITDA – for the nine months ended
YTD 2021 | YTD 2020 | |||||
$'000 | $'000 | |||||
Net income | 181,012 |
|
29,921 |
|
||
Loss from discontinued operations, net of income taxes | - |
|
43 |
|
||
Interest expense from continuing operations | 34,385 |
|
34,385 |
|
||
Income tax expense from continuing operations | 43,290 |
|
8,731 |
|
||
EBIT | 258,687 |
|
73,080 |
|
||
Depreciation | 86,659 |
|
82,135 |
|
||
Amortization | 8,214 |
|
8,613 |
|
||
Net unrealized loss (gain) on derivative instruments | 2,291 |
|
(6,343 |
) |
||
Fair value movement on contingent consideration | 1,130 |
|
(693 |
) |
||
Impairment of PP&E | - |
|
1,239 |
|
||
Dole transaction costs | - |
|
29,000 |
|
||
Net unrealized (gain) loss on foreign denominated intercompany borrowings | (7,256 |
) |
10,111 |
|
||
Restructuring charges / onerous leases | (375 |
) |
1,178 |
|
||
Fair value adjustments arising on PPA exercise | - |
|
86,246 |
|
||
Gain on asset sales | (9,292 |
) |
(7,649 |
) |
||
Loss on disposal of a business | 617 |
|
- |
|
||
Gain on disposal of equity method investments | (1,096 |
) |
- |
|
||
Fair value loss of Legacy Dole acquisition | - |
|
1,985 |
|
||
Fair value gain on other acquisitions | (7,909 |
) |
- |
|
||
COVID-19 | - |
|
10,878 |
|
||
Insurance proceeds / disposals / asset write downs | (19,382 |
) |
- |
|
||
Legal matters | 14,610 |
|
(56 |
) |
||
Dole plc Share of Joint Ventures: | ||||||
Interest expense | 1,113 |
|
1,134 |
|
||
Income tax | 3,174 |
|
2,863 |
|
||
Depreciation | 4,099 |
|
4,082 |
|
||
Amortization | 2,462 |
|
2,138 |
|
||
Adjusted EBITDA | 337,746 |
|
299,941 |
|
Reconciliation from Pro-Forma Net Income to Pro-Forma Adjusted Net Income – for the three months ended
Q3 2021 | Q3 2020 | |||||||
$'000 | $'000 | |||||||
Profit for the financial year attributable to equity shareholders |
|
29,893 |
|
|
18,556 |
|
||
Adjustments: | ||||||||
Amortization of acquisition related intangible assets (subsidiaries) |
|
2,664 |
|
|
2,993 |
|
||
Net unrealized (gain)/loss on derivative financial instruments |
|
627 |
|
|
1,071 |
|
||
Fair value movements on contingent consideration |
|
30 |
|
|
56 |
|
||
Restructuring/Onerous Leases |
|
(125 |
) |
|
487 |
|
||
Gain on disposal of business |
|
2,134 |
|
|
- |
|
||
Gain on asset sales |
|
(4,610 |
) |
|
(5,325 |
) |
||
Fair value (gain) loss on other acquisitions |
|
(5,304 |
) |
|
- |
|
||
COVID-19 |
|
- |
|
|
7,872 |
|
||
PPA fair value adjustments |
|
- |
|
|
17,021 |
|
||
Insurance Proceeds |
|
(9,838 |
) |
|
(56 |
) |
||
Net unrealized (gain) loss on foreign denominated intercompany borrowings |
|
(3,229 |
) |
|
6,021 |
|
||
Exceptional tax on items above |
|
1,991 |
|
|
(8,611 |
) |
||
Discrete tax items |
|
(10,070 |
) |
|
(8,433 |
) |
||
Deferred tax on intangible assets amortization - subsidiaries |
|
(419 |
) |
|
(409 |
) |
||
NCI impact of intangible asset amortization (net of tax) |
|
(923 |
) |
|
(935 |
) |
||
NCI impact of acq related costs and FV movements on contingent consid. |
|
(4 |
) |
|
- |
|
||
Items in earnings for equity method investments: | ||||||||
Group share of amortization of acquisition related intangible assets |
|
972 |
|
|
675 |
|
||
Group share of exceptional tax (credit)/charge on items above |
|
(123 |
) |
|
(118 |
) |
||
Adjusted earnings for EPS calculation |
|
3,666 |
|
|
30,865 |
|
||
Weighted average number of shares at end of period ('000) |
|
94,878 |
|
|
94,878 |
|
||
Adjusted basic earnings per share | $ |
0.04 |
|
$ |
0.33 |
|
||
Diluted weighted average number of shares ('000) |
|
95,030 |
|
|
95,030 |
|
||
Adjusted fully diluted earnings per share | $ |
0.04 |
|
$ |
0.32 |
|
Reconciliation from Pro-Forma Net Income to Pro-Forma Adjusted Net Income – for the nine months ended
YTD 2021 | YTD 2020 | |||||||
$'000 | $'000 | |||||||
Profit (loss) for the financial year attributable to equity shareholders |
|
159,787 |
|
|
12,855 |
|
||
Adjustments: | ||||||||
Amortization of acquisition related intangible assets (subsidiaries) |
|
8,214 |
|
|
8,613 |
|
||
Net unrealized loss/(gain) on derivative financial instruments |
|
2,291 |
|
|
(6,343 |
) |
||
Fair value movements on contingent consideration |
|
1,130 |
|
|
(694 |
) |
||
Restructuring/Onerous Leases |
|
(375 |
) |
|
1,178 |
|
||
Gain on disposal of business |
|
617 |
|
|
- |
|
||
Gain on asset sales |
|
(9,292 |
) |
|
(7,649 |
) |
||
Fair value gain on other acquisitions |
|
(7,909 |
) |
|
- |
|
||
Legal Matters |
|
14,610 |
|
|
- |
|
||
COVID-19 |
|
- |
|
|
10,878 |
|
||
Dole Transaction Costs |
|
- |
|
|
29,000 |
|
||
Impairment of PPE |
|
- |
|
|
1,239 |
|
||
PPA fair value adjustments |
|
- |
|
|
86,246 |
|
||
Insurance Proceeds |
|
(19,382 |
) |
|
(56 |
) |
||
Net unrealized (gain) loss on foreign denominated intercompany borrowings |
|
(7,256 |
) |
|
10,111 |
|
||
Fair value loss on Dole |
|
- |
|
|
1,985 |
|
||
Loss on disposal of equity method investments |
|
(1,096 |
) |
|
- |
|
||
Exceptional tax on items above |
|
578 |
|
|
(30,102 |
) |
||
Discrete tax items |
|
(8,386 |
) |
|
(7,735 |
) |
||
Deferred tax on intangible assets amortization - subsidiaries |
|
(1,210 |
) |
|
(1,013 |
) |
||
NCI impact of intangible asset amortization (net of tax) |
|
(2,754 |
) |
|
(2,820 |
) |
||
NCI impact of acq related costs and FV movements on contingent consid. |
|
(12 |
) |
|
- |
|
||
Items in earnings for equity method investments: | ||||||||
Group share of amortization of acquisition related intangible assets |
|
2,462 |
|
|
2,138 |
|
||
Group share of exceptional tax (credit)/charge on items above |
|
(372 |
) |
|
(350 |
) |
||
Adjusted earnings for EPS calculation |
|
131,645 |
|
|
107,481 |
|
||
Weighted average number of shares at end of period ('000) |
|
94,878 |
|
|
94,878 |
|
||
Adjusted basic earnings per share (cent) | $ |
1.39 |
|
$ |
1.13 |
|
||
Diluted weighted average number of shares ('000) |
|
95,030 |
|
|
95,030 |
|
||
Adjusted fully diluted earnings per share (cent) | $ |
1.39 |
|
$ |
1.13 |
|
Pro-Forma Reconciliation – for the nine months ended
TP | DFC | FV & Interco Adj |
Trans- Action Costs |
Costs |
Debt Adj | Tax Adj | Pro Forma Financial Statements |
||||||||||||||||||||
$'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | |||||||||||||||||||
Revenues, net |
|
3,447,702 |
|
|
3,639,105 |
|
|
7,086,807 |
|
|
(11,902 |
) |
|
- |
|
- |
|
|
- |
|
|
- |
|
|
7,074,905 |
|
|
Cost of sales |
|
(3,166,598 |
) |
|
(3,338,768 |
) |
|
(6,505,366 |
) |
|
15,633 |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
(6,489,733 |
) |
|
Gross profit |
|
281,104 |
|
|
300,337 |
|
|
581,441 |
|
|
3,731 |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
585,172 |
|
|
Selling, marketing and general and administrative expenses |
|
(214,248 |
) |
|
(163,390 |
) |
|
(377,638 |
) |
|
5 |
|
|
4,045 |
|
(5,300 |
) |
|
- |
|
|
- |
|
|
(378,888 |
) |
|
Merger transaction, litigation settlement and other related costs, net |
|
(22,653 |
) |
|
- |
|
|
(22,653 |
) |
|
- |
|
|
22,653 |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Gain on disposal of business |
|
(595 |
) |
|
- |
|
|
(595 |
) |
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
(595 |
) |
|
Impairment of PP&E |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Gain on asset sales |
|
- |
|
|
12,381 |
|
|
12,381 |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
12,381 |
|
|
Operating income (loss) |
|
43,608 |
|
|
149,328 |
|
|
192,936 |
|
|
3,736 |
|
|
26,698 |
|
(5,300 |
) |
|
- |
|
|
- |
|
|
218,070 |
|
|
Other income |
|
2,417 |
|
|
16,423 |
|
|
18,840 |
|
|
971 |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
19,811 |
|
|
Interest income |
|
1,332 |
|
|
1,877 |
|
|
3,209 |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
3,209 |
|
|
Interest expense |
|
(11,392 |
) |
|
(42,465 |
) |
|
(53,857 |
) |
|
- |
|
|
- |
|
- |
|
|
19,472 |
|
|
- |
|
|
(34,385 |
) |
|
Income (loss) from continuing operations before income taxes and equity earnings |
|
35,965 |
|
|
125,163 |
|
|
161,128 |
|
|
4,707 |
|
|
26,698 |
|
(5,300 |
) |
|
19,472 |
|
|
- |
|
|
206,705 |
|
|
Income tax (provision) benefit |
|
(14,062 |
) |
|
(19,299 |
) |
|
(33,361 |
) |
|
- |
|
|
- |
|
1,667 |
|
|
(6,123 |
) |
|
(5,473 |
) |
|
(43,290 |
) |
|
Equity in net earnings of investments accounted for under the equity method |
|
44,357 |
|
|
(313 |
) |
|
44,044 |
|
|
(26,447 |
) |
|
- |
|
- |
|
|
- |
|
|
- |
|
|
17,597 |
|
|
Income from continuing operations, net of income taxes |
|
66,260 |
|
|
105,551 |
|
|
171,811 |
|
|
(21,740 |
) |
|
26,698 |
|
(3,633 |
) |
|
13,349 |
|
|
(5,473 |
) |
|
181,012 |
|
|
Income from discontinued operations, net of income taxes |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
Net income (loss) |
|
66,260 |
|
|
105,551 |
|
|
171,811 |
|
|
(21,740 |
) |
|
26,698 |
|
(3,633 |
) |
|
13,349 |
|
|
(5,473 |
) |
|
181,012 |
|
|
Less: Net income attributable to noncontrolling interests |
|
(18,969 |
) |
|
(2,256 |
) |
|
(21,225 |
) |
|
- |
|
|
- |
|
- |
|
|
- |
|
|
- |
|
|
(21,225 |
) |
|
Net income (loss) attributable to |
|
47,291 |
|
|
103,295 |
|
|
150,586 |
|
|
(21,740 |
) |
|
26,698 |
|
(3,633 |
) |
|
13,349 |
|
|
(5,473 |
) |
|
159,787 |
|
|
Earnings per share: | |||||||||||||||||||||||||||
Net income (loss) per share - Basic | $ |
0.50 |
|
$ |
1.09 |
|
$ |
1.59 |
|
$ |
(0.23 |
) |
$ |
0.28 |
$ |
(0.04 |
) |
$ |
0.14 |
|
$ |
(0.06 |
) |
$ |
1.68 |
|
|
Net income (loss) per share - Diluted | $ |
0.50 |
|
$ |
1.09 |
|
$ |
1.58 |
|
$ |
(0.23 |
) |
$ |
0.28 |
$ |
(0.04 |
) |
$ |
0.14 |
|
$ |
(0.06 |
) |
$ |
1.68 |
|
|
Weighted average shares outstanding | |||||||||||||||||||||||||||
Basic |
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
Diluted |
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
Pro-Forma Reconciliation – for the nine months ended
TP | DFC | FV & Interco Adj |
Trans- Action Costs |
Costs |
Debt Adj | Tax Adj | Pro Forma Financial Statements |
||||||||||||||||||||
$'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | |||||||||||||||||||
Revenues, net |
|
3,291,284 |
|
|
3,513,129 |
|
|
6,804,413 |
|
|
(36,400 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
6,768,013 |
|
|
Cost of products sold |
|
(3,044,704 |
) |
|
(3,226,038 |
) |
|
(6,270,742 |
) |
|
(46,018 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(6,316,760 |
) |
|
Gross profit |
|
246,580 |
|
|
287,091 |
|
|
533,671 |
|
|
(82,418 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
451,253 |
|
|
Selling, marketing and general and administrative expenses |
|
(196,602 |
) |
|
(150,930 |
) |
|
(347,532 |
) |
|
- |
|
|
- |
|
|
(10,500 |
) |
|
- |
|
|
- |
|
(358,032 |
) |
|
Merger transaction, litigation settlement and other related costs, net |
|
(392 |
) |
|
- |
|
|
(392 |
) |
|
- |
|
|
(28,608 |
) |
|
- |
|
|
- |
|
|
- |
|
(29,000 |
) |
|
Impairment of PP&E |
|
(1,210 |
) |
|
- |
|
|
(1,210 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(1,210 |
) |
|
Gain on asset sales |
|
- |
|
|
7,843 |
|
|
7,843 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
7,843 |
|
|
Operating income (loss) |
|
48,376 |
|
|
144,004 |
|
|
192,380 |
|
|
(82,418 |
) |
|
(28,608 |
) |
|
(10,500 |
) |
|
- |
|
|
- |
|
70,854 |
|
|
Other income (loss) |
|
3,052 |
|
|
(14,663 |
) |
|
(11,611 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(11,611 |
) |
|
Interest income |
|
1,741 |
|
|
2,177 |
|
|
3,918 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
3,918 |
|
|
Interest expense |
|
(7,738 |
) |
|
(62,536 |
) |
|
(70,274 |
) |
|
- |
|
|
- |
|
|
- |
|
|
35,889 |
|
|
- |
|
(34,385 |
) |
|
Income (loss) from continuing operations before income taxes and equity earnings |
|
45,431 |
|
|
68,982 |
|
|
114,413 |
|
|
(82,418 |
) |
|
(28,608 |
) |
|
(10,500 |
) |
|
35,889 |
|
|
- |
|
28,776 |
|
|
Income tax (provision) benefit |
|
(13,095 |
) |
|
(23,682 |
) |
|
(36,777 |
) |
|
20,604 |
|
|
- |
|
|
3,302 |
|
|
(11,285 |
) |
|
15,425 |
|
(8,731 |
) |
|
Equity in net earnings of investments accounted for under the equity method |
|
27,719 |
|
|
902 |
|
|
28,621 |
|
|
(18,702 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
9,919 |
|
|
Income from continuing operations, net of income taxes |
|
60,055 |
|
|
46,202 |
|
|
106,257 |
|
|
(80,516 |
) |
|
(28,608 |
) |
|
(7,198 |
) |
|
24,604 |
|
|
15,425 |
|
29,964 |
|
|
Loss from discontinued operations, net of income taxes |
|
- |
|
|
(43 |
) |
|
(43 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(43 |
) |
|
Net income (loss) |
|
60,055 |
|
|
46,159 |
|
|
106,214 |
|
|
(80,516 |
) |
|
(28,608 |
) |
|
(7,198 |
) |
|
24,604 |
|
|
15,425 |
|
29,921 |
|
|
Less: Net income attributable to noncontrolling interests |
|
(15,127 |
) |
|
(1,939 |
) |
|
(17,066 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
(17,066 |
) |
|
Net income (loss) attributable to |
|
44,928 |
|
|
44,220 |
|
|
89,148 |
|
|
(80,516 |
) |
|
(28,608 |
) |
|
(7,198 |
) |
|
24,604 |
|
|
15,425 |
|
12,855 |
|
|
Earnings per share: | |||||||||||||||||||||||||||
Net income (loss) per share - Basic | $ |
0.47 |
|
$ |
0.47 |
|
$ |
0.94 |
|
$ |
(0.85 |
) |
$ |
(0.30 |
) |
$ |
(0.08 |
) |
$ |
0.27 |
|
$ |
0.16 |
$ |
0.14 |
|
|
Net income (loss) per share - Diluted | $ |
0.47 |
|
$ |
0.47 |
|
$ |
0.94 |
|
$ |
(0.85 |
) |
$ |
(0.30 |
) |
$ |
(0.08 |
) |
$ |
0.27 |
|
$ |
0.16 |
$ |
0.14 |
|
|
Weighted average shares outstanding | |||||||||||||||||||||||||||
Basic |
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
|
94,878 |
|
94,878 |
|
|
Diluted |
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
|
95,030 |
|
95,030 |
|
Quarterly Information
2021 |
||||||||||||||||||
Q1 | Q2 | Q3 | YTD Q3 | |||||||||||||||
$'000 | $'000 | $'000 | $'000 | |||||||||||||||
Revenue |
|
2,279,847 |
|
2,477,600 |
|
2,317,458 |
|
7,074,905 |
||||||||||
Adjusted EBITDA |
|
132,944 |
|
145,075 |
|
59,727 |
|
337,746 |
||||||||||
Earnings per Share | $ |
0.62 |
$ |
0.75 |
$ |
0.32 |
$ |
1.68 |
||||||||||
Adjusted Earnings per Share | $ |
0.63 |
$ |
0.72 |
$ |
0.04 |
$ |
1.39 |
||||||||||
2020 |
||||||||||||||||||
Q1 | Q2 | Q3 | YTD Q3 | Q4 | FY | |||||||||||||
$'000 | $'000 | $'000 | $'000 | $'000 | $'000 | |||||||||||||
Revenue |
|
2,179,718 |
|
2,278,322 |
|
2,309,973 |
|
6,768,013 |
|
2,201,392 |
|
8,969,405 |
||||||
Adjusted EBITDA |
|
97,646 |
|
109,885 |
|
92,410 |
|
299,941 |
|
71,840 |
|
371,781 |
||||||
Earnings per Share | $ |
(0.35) |
$ |
0.29 |
$ |
0.20 |
$ |
0.14 |
$ |
0.01 |
$ |
0.15 |
||||||
Adjusted Earnings per Share | $ |
0.44 |
$ |
0.37 |
$ |
0.32 |
$ |
1.13 |
$ |
0.21 |
$ |
1.34 |
The following tables reconciles Revenue and Adjusted EBITDA as reported in the Dole plc Third Quarter 2021 Financial Statements to Pro-Forma Revenue and Pro-Forma Adjusted EBITDA for the three months ended
Q3 2021 | Q3 2020 | |||||
$'000 | $'000 | |||||
Revenue per Q3 Financial Statements of |
1,942,185 |
|
1,188,449 |
|
||
Incremental revenue of |
383,208 |
|
1,133,824 |
|
||
Effect of intercompany transactions in period | (7,935 |
) |
(12,300 |
) |
||
Pro Forma Revenue | 2,317,458 |
|
2,309,973 |
|
||
YTD Q3 2021 | YTD Q3 2020 | |||||
$'000 | $'000 | |||||
Revenue per Q3 Financial Statements of |
4,202,922 |
|
3,291,284 |
|
||
Incremental revenue of |
2,883,885 |
|
3,513,129 |
|
||
Effect of intercompany transactions in period | (11,902 |
) |
(36,400 |
) |
||
Pro Forma Revenue | 7,074,905 |
|
6,768,013 |
|
Q3 2021 | Q3 2020 | |||||
$'000 | $'000 | |||||
Adjusted EBITDA per Q3 Financial Statements of |
54,938 |
|
66,355 |
|
||
Less EBITDA of equity accounted |
(1,765 |
) |
(25,494 |
) |
||
Incremental EBITDA of |
4,354 |
|
55,049 |
|
||
Pro Forma public company costs | 2,200 |
|
(3,500 |
) |
||
Pro Forma Adjusted EBITDA | 59,727 |
|
92,410 |
|
||
YTD Q3 2021 | YTD Q3 2020 | |||||
$'000 | $'000 | |||||
Adjusted EBITDA per Q3 Financial Statements of |
229,015 |
|
197,071 |
|
||
Less EBITDA of equity accounted |
(93,353 |
) |
(95,730 |
) |
||
Incremental EBITDA of |
207,384 |
|
209,100 |
|
||
Pro Forma public company costs | (5,300 |
) |
(10,500 |
) |
||
Pro Forma Adjusted EBITDA | 337,746 |
|
299,941 |
|
* Incremental from DFC relates to periods from
ASSETS | ( |
|||||||
Cash and cash equivalents | $ |
234,214 |
|
$ |
160,503 |
|
||
Short-term investments |
|
5,703 |
|
|
- |
|
||
Trade receivables, net of allowances of |
|
776,913 |
|
|
365,937 |
|
||
Grower advance receivables, net of allowances of |
|
100,800 |
|
|
18,946 |
|
||
Other receivables, net of allowances of |
|
115,550 |
|
|
24,324 |
|
||
Inventories, net of allowances of |
|
421,762 |
|
|
141,179 |
|
||
Prepaid expenses |
|
53,403 |
|
|
16,570 |
|
||
Other current assets |
|
12,703 |
|
|
2,936 |
|
||
Assets held-for-sale |
|
435 |
|
|
- |
|
||
Total current assets |
|
1,721,483 |
|
|
730,395 |
|
||
Long-term investments |
|
24,491 |
|
|
- |
|
||
Investments in unconsolidated affiliates |
|
126,774 |
|
|
458,557 |
|
||
Actively marketed property |
|
50,638 |
|
|
- |
|
||
Property, plant and equipment, net of accumulated depreciation of |
|
1,446,773 |
|
|
219,665 |
|
||
Operating lease right-of-use assets |
|
363,990 |
|
|
140,212 |
|
||
|
511,133 |
|
|
234,161 |
|
|||
Dole brand |
|
306,280 |
|
|
- |
|
||
Other intangible assets, net of accumulated amortization of |
|
63,221 |
|
|
65,634 |
|
||
Other assets, net |
|
75,592 |
|
|
30,496 |
|
||
Deferred income tax assets |
|
39,569 |
|
|
6,682 |
|
||
Total assets | $ |
4,729,944 |
|
$ |
1,885,802 |
|
||
LIABILITIES AND EQUITY | ||||||||
Accounts payable | $ |
696,433 |
|
$ |
474,528 |
|
||
Income taxes payable |
|
21,484 |
|
|
2,589 |
|
||
Accrued liabilities |
|
431,344 |
|
|
92,279 |
|
||
Bank overdrafts |
|
27,579 |
|
|
11,243 |
|
||
Notes payable and current portion of long-term debt, net |
|
52,241 |
|
|
20,748 |
|
||
Current maturities of operating leases |
|
68,449 |
|
|
21,910 |
|
||
Other tax |
|
52,158 |
|
|
23,371 |
|
||
Contingent consideration |
|
6,266 |
|
|
4,912 |
|
||
Pension and postretirement benefits |
|
20,608 |
|
|
5,787 |
|
||
Other current liabilities |
|
59,187 |
|
|
32,539 |
|
||
Total current liabilities |
|
1,435,749 |
|
|
689,906 |
|
||
Long-term debt, net |
|
1,262,334 |
|
|
314,840 |
|
||
Operating leases, less current maturities |
|
306,634 |
|
|
122,225 |
|
||
Deferred income tax liabilities |
|
149,647 |
|
|
22,451 |
|
||
Contingent consideration, less current portion |
|
3,835 |
|
|
5,786 |
|
||
Pension and postretirement benefits, less current portion |
|
158,167 |
|
|
23,607 |
|
||
Other long-term liabilities |
|
133,417 |
|
|
18,755 |
|
||
Total liabilities | $ |
3,449,783 |
|
$ |
1,197,570 |
|
||
Commitments and contingent liabilities: | ||||||||
Redeemable noncontrolling interests |
|
31,627 |
|
|
30,317 |
|
||
Stockholders’ equity: | ||||||||
Common stock— |
|
949 |
|
|
4,865 |
|
||
Additional paid-in capital |
|
794,085 |
|
|
198,232 |
|
||
Retained earnings |
|
450,193 |
|
|
460,715 |
|
||
Accumulated other comprehensive loss |
|
(128,485 |
) |
|
(128,803 |
) |
||
Total equity attributable to |
|
1,116,742 |
|
|
535,009 |
|
||
Equity attributable to noncontrolling interests |
|
131,792 |
|
|
122,906 |
|
||
Total equity |
|
1,248,534 |
|
|
657,915 |
|
||
Total liabilities, redeemable noncontrolling interests and equity | $ |
4,729,944 |
|
$ |
1,885,802 |
|
Dole plc’s results are determined in accordance with
In addition to its results under GAAP, in this Press Release we also present Dole plc’s Pro-Forma EBIT, Pro-Forma Adjusted EBITDA, Pro-Forma Adjusted net income attributable to
Pro-Forma EBIT before discontinued operations is calculated from net income (loss) by adding interest expense from continuing operations and adding the income tax expense or subtracting the income tax benefit from continuing operations.
Pro-Forma Adjusted EBITDA is calculated from EBIT before discontinued operations by: (1) adding depreciation and amortization charges; (2) adding merger, transaction and other related costs; (3) adding the net unrealized loss or subtracting the net unrealized gain on derivative instruments; (4) adding the net unrealized loss or subtracting the net unrealized gain on foreign denominated intercompany borrowings; (5) adding the net realized loss or subtracting the net realized gain on noncash settled foreign denominated intercompany borrowings; (6) adding or subtracting fair value movements on contingent consideration; (7) adding impairment charges on goodwill, intangible assets and property, plant and equipment, net of insurance proceeds; (8) adding or subtracting asset write-downs, net of insurance proceeds; (9) adding restructuring charges or onerous contract costs; (10) adding the loss or subtracting the gain on asset sales for assets held-for-sale and actively marketed property; (11) deducting the fair value gain or adding the fair value loss on the acquisition of investments previously accounted for under the equity method; (12) deducting the gain or adding the loss on the sale of investments accounted for under the equity method or other business interests; (13) adding costs for legal matters not in the ordinary course of business; and (14) adding costs that are directly related to the COVID-19 pandemic, and are as follows: costs that are (i) incremental to charges incurred prior to the outbreak, (ii) not expected to recur once the crisis has subsided and operations return to normal and (iii) clearly separable from normal operations. It also includes the Company’s share of all listed items within investments accounted for under the equity method.
Pro-Forma Adjusted Net Income attributable to
Pro-Forma Adjusted Earnings per Share is calculated from Pro-Forma Adjusted Net Income attributable to
However, Pro-Forma EBIT before discontinued operations, Pro-Forma Adjusted EBITDA, and Pro-Forma Adjusted Net Income attributable to
- They do not reflect Dole plc’s cash expenditures, or future requirements, for capital expenditures or contractual commitments;
- They do not reflect changes in, or cash requirements for, Dole plc’s working capital needs;
- They do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on Dole plc’s debt; and
- Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and these non-GAAP measures do not reflect cash requirements for such replacements.
Because of these limitations, Pro-Forma EBIT before discontinued operations and Pro-Forma Adjusted EBITDA should not be considered as measures of discretionary cash available to
Further, Pro-Forma EBIT before discontinued operations, Pro-Forma Adjusted EBITDA, and Pro Forma Adjusted Net Income attributable to
About
A global leader in fresh produce,
Webcast and Conference Call Information
An archived replay of the webcast will also be available shortly after the live event has concluded. For those without internet access, the conference call can be accessed live by dialing 1-855-979-6564 or for international callers by dialing +44 203 936 2999. The access code is 683777.
A replay of the call will be available through
Forward-looking information
Certain statements made in this press release that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management’s beliefs, assumptions, and expectations of our future economic performance, considering the information currently available to management. These statements are not statements of historical fact. The words “believe,” “may,” “could,” “will,” “should,” “would,” “anticipate,” “estimate,” “expect,” “intend,” “objective,” “seek,” “strive,” “target” or similar words, or the negative of these words, identify forward-looking statements. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made except as required by the federal securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211203005213/en/
Investor Contact:
James O Regan, Head of Investor Relations,
joregan@totalproduce.com
Media Contact:
philip.elwood@ogilvy.com
+1 202 423 7957
julianna.richter@ogilvy.com
+1 646 427 4185
brian.bell@ogilvy.com
+353 87 2436 130
Source:
FAQ
What were the Q3 2021 financial results for Dole plc (DOLE)?
How did Dole plc's year-to-date revenue perform in 2021 compared to 2020?
What is the full-year financial outlook for Dole plc for 2021?